Medical Condition News

RSS

The Leonardo da Vinci Prize competition invites project submissions

International philanthropists, prestigious Universities, Hospitals, Order of Physicians, Public Administrations support and sponsor this initiative to follow scientific procedures to identify solutions with the highest potential to reduce premature cancer death and cost.

13 May 2011

CEL-SCI initiates Multikine Phase III trial for head and neck cancer in Poland

CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, at the Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Warsaw, Poland, the first clinical site in Poland and the first center in the EU.

13 May 2011

China's SFDA approves TPI anti-diabetic drug Gliclazide

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals today announced that TPI has received the China's SFDA's approval for its anti-diabetic drug Gliclazide Tablets.

13 May 2011

Mylan introduces Risperidone Orally Disintegrating Tablets for schizophrenia treatment

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Risperidone Orally Disintegrating Tablets, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg, the generic version of Ortho-McNeil's Risperdal M-Tab, a treatment for schizophrenia.

13 May 2011

PAF, Breakaway from Cancer partner for awareness campaign

The Patient Advocate Foundation – a national non-profit organization that provides professional case management services to tens of thousands of patients every year who are unable to obtain access to care because of financial or insurance denials - is pleased to partner with Breakaway from Cancer, a national fundraising and educational initiative founded by Amgen in 2005 as a complementary component to the company's sponsorship of the Amgen Tour of California, a world-class professional cycling competition, to raise awareness of the important resources available to cancer patients including prevention, education, patient care, advocacy, financial support and survivorship.

13 May 2011

Researcher says a comparison with epilepsy is an appropriate prism to view economics

Since 2008, the U.S. economy has been "seizing" uncontrollably. Now a Tel Aviv University researcher says that a comparison of the multifaceted economic downturn with the uncontrolled spasms of an epileptic is not inappropriate - and may say something about the origins of the disaster.

13 May 2011

ZIOPHARM submits IND with FDA for Ad-RTS-IL-12 Phase I study in cancer

ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food & Drug Administration (FDA) to begin clinical study of Ad-RTS-IL-12, a novel DNA-based therapeutic candidate.

13 May 2011

PROTECT II study data in high-risk percutaneous coronary intervention to be presented at EuroPCR

Abiomed Inc., a leading provider of breakthrough heart support technologies, today announced that data from the PROTECT II study will be presented by Jeffrey W. Moses, M.D., Director of Interventional Services at NewYork-Presbyterian Hospital/Columbia University - Cornell Medical Center, during the late-breaking registries and clinical trial update session at EuroPCR 2011 in Paris.

13 May 2011

Researchers untangle two distinct ways in which tumor-suppressor protein works

Researchers at the Stanford University School of Medicine have untangled two distinct ways in which a common, naturally occurring "tumor-suppressor" protein works.

13 May 2011

PCR testing for B. burgdorferi bacteria in joint fluid may confirm Lyme arthritis diagnosis

New research shows that polymerase chain reaction testing for Borrelia burgdorferi DNA—the spirochetal bacteria transmitted by deer ticks—in joint fluid may confirm the diagnosis of Lyme arthritis, but is not a reliable indicator for active joint infection in patients whose arthritis persists after antibiotic therapy. Findings of this study are published in Arthritis & Rheumatism, a journal of the American College of Rheumatology.

13 May 2011

Spouse caregivers may have high risk of cognitive impairment or dementia

An older individual who cares for a spouse with dementia may be at an increased risk of developing cognitive problems because of the lifestyle that was shared with the spouse and because of the stress of caring for a loved one who is ill.

13 May 2011

ISCO announces near-term marketing plans for Lifeline Skin Care products

International Stem Cell Corporation today announced the Company's near-term marketing plans for products manufactured by its Lifeline Skin Care subsidiary.

13 May 2011

People with sudden cardiac arrest at District libraries now have access to Automatic External Defibrillators

People who suffer sudden cardiac arrest at District libraries now have access to Automatic External Defibrillators at all locations thanks to a partnership between the Federation of Friends of DC Public Library, Mended Hearts, Inc. and The George Washington University Cheney Cardiovascular Institute.

13 May 2011

AHRQ: Rural Americans more likely to be treated in emergency departments for eye injury

Rural Americans were five times more likely than urban residents to be treated in emergency departments for eye injuries in 2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

13 May 2011

Midbrain habenula region plays a key role in nicotine dependence

A person's vulnerability to nicotine addiction appears to have a genetic basis, at least in part. A region in the midbrain called the habenula plays a key role in this process, as Dr. In-s Iba-ez-Tallon and her team from the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have now shown.

13 May 2011

Researchers uncover unexpected role of estrogen receptors in brain inflammation

Researchers have uncovered an unexpected role for estrogen receptors in the brain in keeping inflammation under control. The findings reported in the May 13 issue of the Cell Press journal Cell may have important implications for the treatment of multiple sclerosis (MS) and many other neurodegenerative diseases.

13 May 2011

Elevated levels of cardiac troponins T or I after angioplasty linked to long-term all-cause mortality

New research shows that elevated levels of cardiac troponin T (cTnT) or I (cTnI) in patients who had angioplasty indicate a higher risk of all-cause mortality and long-term adverse events such as heart attack.

13 May 2011

New study sheds light on origins of myeloid leukemia

A new study by the NYU Cancer Institute, an NCI-designated cancer center, sheds light on the origins of myeloid leukemia, a type of blood cancer that affects children and adults.

13 May 2011

Leading public health experts agree: Menthol ban could save thousands of lives

Today, as the U.S. Food and Drug Administration continues to weigh a potential menthol ban, the American Academy of Pediatrics, American Public Health Association, Center for American Progress and Legacy called for menthol cigarettes to be taken off the market, citing key findings published today in the American Journal of Public Health.

13 May 2011

Patients with sickle cell disease may require higher, frequent doses of morphine

Frequent episodes of severe pain occur in patients with sickle cell disease (SCD) and require treatment with potent opioid medications. A new study published in The Journal of Pain reports that SCD patients clear morphine from their blood stream quickly and, therefore, require high doses to achieve optimal analgesia.

13 May 2011

Medical Condition News

The Leonardo da Vinci Prize competition invites project submissions

CEL-SCI initiates Multikine Phase III trial for head and neck cancer in Poland

China's SFDA approves TPI anti-diabetic drug Gliclazide

Mylan introduces Risperidone Orally Disintegrating Tablets for schizophrenia treatment

PAF, Breakaway from Cancer partner for awareness campaign

Researcher says a comparison with epilepsy is an appropriate prism to view economics

ZIOPHARM submits IND with FDA for Ad-RTS-IL-12 Phase I study in cancer

PROTECT II study data in high-risk percutaneous coronary intervention to be presented at EuroPCR

Researchers untangle two distinct ways in which tumor-suppressor protein works

PCR testing for B. burgdorferi bacteria in joint fluid may confirm Lyme arthritis diagnosis

Spouse caregivers may have high risk of cognitive impairment or dementia

ISCO announces near-term marketing plans for Lifeline Skin Care products

People with sudden cardiac arrest at District libraries now have access to Automatic External Defibrillators

AHRQ: Rural Americans more likely to be treated in emergency departments for eye injury

Midbrain habenula region plays a key role in nicotine dependence

Researchers uncover unexpected role of estrogen receptors in brain inflammation

Elevated levels of cardiac troponins T or I after angioplasty linked to long-term all-cause mortality

New study sheds light on origins of myeloid leukemia

Leading public health experts agree: Menthol ban could save thousands of lives

Patients with sickle cell disease may require higher, frequent doses of morphine

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News